HPLC assay method for determining Amphotericin B levels in serum and tissue specimens

ID: 16

Group:

Assaying antifungal levels

Prepared by:

Dr Elizabeth Johnson

Detail:

Monitoring of serum concentrations of amphotericin B during treatment is seldom indicated. The optimum serum concentrations of the drug for particular fungal infections have not been determined. Although amphotericin B is nephrotoxic toxicity is determined by monitoring kidney function and higher blood levels do not lead to greater renal impairment.

Year prepared: 2000

Date uploaded: 2010-02-26 14:39:24

Laboratory Protocols

Select from:Additional methods & referenceAflatoxinsAssaying antifungal levelsAssaying mycotoxinsAztec Labs Diagnostic testing ProtocolsBiochemical CalculatorsBiofilmBiotypingCell Component ExtractionClinical BreakpointsCollection of Clinical MaterialCosmidsDetection in clinical samplesDNA extractionEnzyme synthesisFungal Molecular BiologyGeneral Molecular BiologyGeneticsGrowth and StorageHistologyMethods for DNA sequencingMicroscopyModel systems: in vitroModel systems: in vivoMore protocol collectionsPCR  -RT-qPCRPhagocytosisPlanar liquid chromatographyPost Antifungal Effects (PAFE)Preparation of amphotericin pasteProtein methodsProtocol overviewsQuality control in mycologySampling Aspergillus sporesSecondary metabolitesSpecies/Strain identification  -In situ hydridizationStandard Operating Procedures:National Aspergillosis CentreSusceptibility testingVeterinaryVideo Protocols at the FGSCWhole blood fractionationwhole-cell screening